Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages

BACKGROUND: Previous studies of prostate cancer autoantibodies have largely focused on diagnostic applications. So far, there have been no reports attempting to more comprehensively profile the landscape of prostate cancer-associated antibodies. Specifically, it is unknown whether the quantity of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Potluri, Hemanth K, Ng, Tun Lee, Newton, Michael A, Zhang, Jin, Maher, Christopher A, Nelson, Peter S, McNeel, Douglas G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745697/
https://www.ncbi.nlm.nih.gov/pubmed/33335027
http://dx.doi.org/10.1136/jitc-2020-001510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745697/
https://www.ncbi.nlm.nih.gov/pubmed/33335027
http://dx.doi.org/10.1136/jitc-2020-001510

Ejemplares similares